Research Paper Volume 12, Issue 5 pp 4573—4591

APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma

class="figure-viewer-img"

Figure 9. APEX1 is a prognostic biomarker in non-alcoholic, vascular invasion-negative and hepatitis virus infection-negative HCC patients. (A, B) Kaplan-Meier survival curve analysis shows the OS rates of high- and low-APEX1 expressing alcoholic and non-alcoholic HCC patients. (C, D) Kaplan-Meier survival curve analysis shows the OS rates of high- and low-APEX1 expressing vascular invasion-positive and vascular invasion-negative HCC patients. (E, F) Kaplan-Meier survival curve analysis shows the OS rates of high- and low-APEX1 expressing hepatitis virus infection-positive and hepatitis virus infection-negative HCC patients.